日韩不卡在线观看视频不卡,国产亚洲人成A在线V网站,处破女八a片60钟粉嫩,日日噜噜夜夜狠狠va视频

碳二亞胺類(lèi)縮合劑制備酰胺

用碳二亞胺類(lèi)縮合劑縮合制備酰胺在藥物合成中應(yīng)用極為廣泛,目前常用的縮合劑主要有三種:二環(huán)己基碳二亞胺(DCC)、二異丙基碳二亞胺(DIC)1-(3-二甲胺基丙基)-3-乙基碳二亞胺(EDCI)。

 

使用該類(lèi)的縮合劑一般需要加入酰化催化劑或活化劑,如4-N,N-二甲基吡啶(DMAP)、1-羥基苯并三氮唑(HOBt)等等,其主要由于在反應(yīng)的第一階段酸對(duì)碳二亞胺的加成中間體其并不穩(wěn)定,若不用?;呋瘎┺D(zhuǎn)化為相應(yīng)的活性酯或活性酰胺,其自身會(huì)通過(guò)重排成相應(yīng)的穩(wěn)定的脲的副產(chǎn)物 (Path b).


常用的縮合活化劑有以下幾種,目前4-N,N-二甲基吡啶(DMAP)已被廣泛應(yīng)用于催化各種?;磻?yīng)。有時(shí)在用DMAP催化效果不好時(shí),可采用4-PPY,據(jù)相關(guān)文獻(xiàn)報(bào)道其催化能力要比DMAP高千倍左右。

在三個(gè)常用的縮合劑DCCDICEDCI中, DCCDIC的價(jià)格較為便宜,一般DCCDMAP合用,使用DCC有一個(gè)最大的缺點(diǎn)就是反應(yīng)的另一產(chǎn)物二環(huán)己基脲在一般的有機(jī)相溶解度很小但又都有一些微溶,因此通過(guò)一些常用的純化方法,重結(jié)晶,柱層析等等很難將其除得很徹底;由于二環(huán)己基脲在乙醚中的溶解度相對(duì)要比其他溶劑小,因此處理這類(lèi)反應(yīng)一般蒸掉反應(yīng)溶劑后加入乙醚,濾掉大部分的二環(huán)己基脲后再進(jìn)一步處理。DIC由于其產(chǎn)生的二異丙基脲在有一般的有機(jī)溶劑中溶解度較好,因此一般在組合化學(xué)的固相合成中用的較多。

目前,在藥物化學(xué)中用的最多的還是EDCI,其一個(gè)主要的特點(diǎn)就是其反應(yīng)后的生成的脲是水溶性的,很容易被洗掉,一般EDCIHOBt合用(注意這一反應(yīng)HOBt一般是缺不了的,否則有可能導(dǎo)致縮合產(chǎn)率太低)。有時(shí)如果酸的a-位位阻大或者連有吸電子基團(tuán),反應(yīng)會(huì)停留在活性酯這一步(這一活性酯的質(zhì)譜信號(hào)較強(qiáng),可通過(guò)MS或LC-MS檢測(cè)到)。由于HOBt也是水溶性的,其使得反應(yīng)的處理和純化相對(duì)要容易。一般在這一縮合中要加入堿,特別當(dāng)用胺或氨基酸的鹽酸鹽等縮合,常用的是加2-3當(dāng)量的N-甲基嗎啡啉或二異丙基乙胺(DIEA,Hunig base縮合時(shí)以二氯甲烷為溶劑,若底物的溶解度不好,可用DMF作反應(yīng)溶劑,再使用該方法進(jìn)行。


 

在使用該方法進(jìn)行氨基酸縮合時(shí),一般投料必須在零下20~30下進(jìn)行,并在此溫度下攪拌近一小時(shí)后再室溫?cái)嚢瑁駝t其會(huì)引起氨基酸的消旋化。


1、DCC縮合法合成酰胺示例

To a solution of compound 11 (4.06 g, 10 mmol) in DMF (150 mL) wasadded N-hydroxybenzotriazole (HOBt, 5.64 g, 42 mmol), followed by dicyclohexylcarbodiimide (DCC; 8.60 g, 42 mmol). After stirring for l h,a solution of di-tert-butyl 4-amino-4-[2-(tert-butoxycarbonyl)ethyl]heptanedioate5 (17.34 g, 41.7 mmol)in DMF (60 mL) was added and the solution stirred at 25 for 23 h.  The crystals were filtered and washed on thefilter with DMF (25 mL).  The solvent wasdistilled at 50/1mm, and the residual oil was dissolved in ether (600mL).  Crystals were filtered, the ethereal solutionwas washed successively with 10% HCl (2 x100 mL), saturated NaHCO3(2 x 100 mL), and brine (2 x 50 mL), then dried (Na2SO4). The ether solution was filtered throughcelite and solvent was then removed in vacuo to afford 19.0 g of crude product, which waspurified on a silica column eluting with toluene/EtOAc (1:1) to furnish (60%)the white, non-crystalline ester 12:14.0 g; mp 55-60.  1HNMR δ 1.43 (s, CH3, 108H), 1.94-2.28 (m, CH2CH2,64H), 5.87 (s, NH, 4H), 6.17 (s, CH=CH, 2H); 13C NMR (DMSO-d6) δ28.3 (CH3), 29.3 (CH2CH2),56.8 (CNH), 69.0 (CSO2), 171.1 (CO), 171.4 (CO).


2、DIC縮合法合成酰胺示例

To a solution of amine 13 (106 mg, 0.3 mmol),Fmoc-Phe-OH (116 mg, 0.3 mmol), and HOBt (44.8 mg, 0.33 mmol) in anhydrous DMF(2 mL) was added DIC (56 μL, 0.36 mmol).  The resulting mixture was stirred at roomtemperature overnight, and DMF was then evaporated under high vacuum.  The residue was dissolved in ethyl acetate (10mL), washed sequentially with saturated aqueous NaHCO3 and brine,and then dried over Na2SO4.  The evaporation of the solvent gave the crudeproduct that was directly submitted for the Fmoc removal without purification.  The crude product was dissolved in DMF (8 mL),piperidine (2.0 mL) was added, and the resulting solution was stirred at roomtemperature for 1 h.  Following thesolvent evaporation, the residue was purified by silica gel chromatography (50%ethyl acetate in hexanes to 10% methanol in chloroform) to provide product 14(128 mg) in 85% yield as a mixture of two diastereomers. 1H NMR (CDCl3, 400MHz) ‰ 8.12-8.00 (2H, m), 7.90-7.80 (2H, m), 7.70-7.54 (2H, m), 7.42(2H, m), 7.35-7.20 (2H, m), 6.97-6.83 (3H, m), 5.32 (1H, m), 4.32 (1H, m),4.20-4.03 (2H, m), 3.96-3.80 (2H, m), 3.60 (1H, m), 2.98 (3H, m), 2.88 (2H, s),2.60 (1H, s), 2.00 (1H, m), 1.85 (2H, m), 1.77-1.55 (3H, m); MS (ES+) m/z) 501.4 (M + 1).

 

3、應(yīng)用EDC縮合法合成酰胺示例一(二氯甲烷為溶劑)

To a solution of amine16 (0.284 mg, 1.19 mmol) and 5-hexenoic acid 15(0.136 g,1.19 mmol) in CH2Cl2 (12.0 ml) at 0were added HOBt (0.177 g,1.31 mmol) and EDC (0.251 g,1.31 mmol).  The reaction mixture was stirredat room temperature for 10 h, then washed with 5% aqueous HCl (3×15.0 ml), 5% aqueous NaHCO3 (20 .0 ml),H2O (20.0 ml), and brine (20.0 ml), and dried (Na2SO4).  Purification by flash chromatography(CH3Cl/MeOH, 10%, Rf = 0.43) afforded amidoalkene 17 in 99%yield as a brown oil. 

 

4、應(yīng)用EDC縮合法合成酰胺示例二DMF為溶劑)

A DMF solution (10 mL) containing HOBt (103 mg, 0.76mmol), EDC (192 mg, 1.0 mmol), and Boc-D-Ile (172 mg, 0.76 mmol) was stirred atroom temperature for 20 h.  A solution ofthe amino ketal 18 (0.41 g,0.76 mmol) and 4-methylmorpholine (0.17 mL, 1.5 mmol) dissolved in 10 mL of DMFwas then added to the reaction mixture.  After4 h the reaction mixture was partitioned between EtOAc and H2O.  The organic layer was washed with H2O,dried over MgSO4, and concentrated under reduced pressure.  Flash chromatography (4:1 EtOAc/hexanes)afforded the Boc ketal 19 (0.44 g,0.59 mmol, 78%).



本文內(nèi)容來(lái)源于網(wǎng)絡(luò),版權(quán)歸原作者所有


納孚服務(wù)
  • 化學(xué)試劑
  • 提供稀有化學(xué)試劑現(xiàn)貨

  • 化學(xué)試劑定制合成服務(wù)
  • 上海納孚生物科技有限公司提供市場(chǎng)稀缺的化學(xué)試劑定制服務(wù)

  • 新材料現(xiàn)貨
  • 上海納孚生物科技有限公司代理或自產(chǎn)包含石墨烯產(chǎn)品,類(lèi)石墨烯產(chǎn)品、碳納米管、無(wú)機(jī)納米材料以及一些高分子聚合物材料

  • 結(jié)構(gòu)設(shè)計(jì)及定制合成
  • 可以根據(jù)客戶需求對(duì)所需化合物結(jié)構(gòu)進(jìn)行設(shè)計(jì)改性,從而定制合成出客戶所需分子式結(jié)構(gòu)

  • 聯(lián)系我們
  • 021-58952328
  • 13125124762
  • info@chemhui.com
  • 關(guān)注我們
在線客服
live chat